Ascendiant Capital Maintains Buy on Aemetis, Lowers Price Target to $20
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $21 to $20.
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $21 to $20.